Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Niagen Bioscience, Inc. NAGE

Full chart Compare
Set alert

Price alert · NAGE

All alert types
2.36 USD -0.04 (-1.67%)

At closeNov 3, 2026, 4:01 PM EST

2.36 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

2.31 Day range 2.42
2.31 52-week range 7.95
YTD
-62.89%
1 year
-67.36%

Financial health

Altman Z-Score

5.33 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 2

Valuation

P/E 28.9×
FY 2016: -42.2×FY 2017: -22.6×FY 2018: -5.6×FY 2019: -7.7×FY 2020: -14.5×FY 2021: -9.3×FY 2022: -7.0×FY 2023: -20.4×FY 2024: 48.3×FY 2025: 28.9×
FY 2016 5y median -7.0× FY 2025
P/S 3.9×
FY 2016: 5.7×FY 2017: 12.4×FY 2018: 6.0×FY 2019: 5.3×FY 2020: 4.9×FY 2021: 3.7×FY 2022: 1.6×FY 2023: 1.2×FY 2024: 4.3×FY 2025: 3.9×
FY 2016 5y median 3.7× FY 2025
P/B 6.6×
FY 2016: 12.4×FY 2017: 4.9×FY 2018: 6.9×FY 2019: 12.0×FY 2020: 17.8×FY 2021: 7.9×FY 2022: 4.0×FY 2023: 3.5×FY 2024: 9.2×FY 2025: 6.6×
FY 2016 5y median 6.6× FY 2025
P/FCF 38.3×
FY 2016: -26.5×FY 2017: -23.5×FY 2018: -8.4×FY 2019: -11.6×FY 2020: -27.3×FY 2021: -10.2×FY 2022: -7.5×FY 2023: 14.5×FY 2024: 35.4×FY 2025: 38.3×
FY 2016 5y median 14.5× FY 2025
EV/EBITDA 22.5×
FY 2016: -49.2×FY 2017: -13.9×FY 2018: -5.2×FY 2019: -7.7×FY 2020: -15.2×FY 2021: -9.0×FY 2022: -6.8×FY 2023: -23.8×FY 2024: 36.9×FY 2025: 22.5×
FY 2016 5y median -6.8× FY 2025
EV/Sales 3.4×
FY 2016: 5.6×FY 2017: 10.3×FY 2018: 5.3×FY 2019: 4.9×FY 2020: 4.7×FY 2021: 3.4×FY 2022: 1.4×FY 2023: 0.9×FY 2024: 3.8×FY 2025: 3.4×
FY 2016 5y median 3.4× FY 2025
FCF Yield 2.6%
FY 2016: -3.8%FY 2017: -4.3%FY 2018: -11.9%FY 2019: -8.6%FY 2020: -3.7%FY 2021: -9.8%FY 2022: -13.3%FY 2023: 6.9%FY 2024: 2.8%FY 2025: 2.6%
FY 2016 5y median 2.6% FY 2025

Profitability

Gross Margin 64.3%
FY 2016: 48.0%FY 2017: 49.4%FY 2018: 50.9%FY 2019: 55.7%FY 2020: 59.5%FY 2021: 61.5%FY 2022: 59.4%FY 2023: 60.8%FY 2024: 61.8%FY 2025: 64.3%
FY 2016 5y median 61.5% FY 2025
Operating Margin 11.0%
FY 2016: -13.4%FY 2017: -77.2%FY 2018: -105.1%FY 2019: -67.6%FY 2020: -33.5%FY 2021: -40.1%FY 2022: -25.9%FY 2023: -6.7%FY 2024: 7.8%FY 2025: 11.0%
FY 2016 5y median -6.7% FY 2025
Net Margin 13.4%
FY 2016: -13.5%FY 2017: -53.7%FY 2018: -105.6%FY 2019: -69.4%FY 2020: -33.6%FY 2021: -40.2%FY 2022: -23.0%FY 2023: -5.9%FY 2024: 8.6%FY 2025: 13.4%
FY 2016 5y median -5.9% FY 2025
ROE 22.7%
FY 2016: -29.4%FY 2017: -21.1%FY 2018: -122.6%FY 2019: -157.2%FY 2020: -121.3%FY 2021: -85.5%FY 2022: -57.7%FY 2023: -17.4%FY 2024: 18.5%FY 2025: 22.7%
FY 2016 5y median -17.4% FY 2025
ROIC 15.6%
FY 2016: -26.1%FY 2017: -29.9%FY 2018: -118.6%FY 2019: -120.2%FY 2020: -88.2%FY 2021: -66.4%FY 2022: -50.5%FY 2023: -16.0%FY 2024: 14.5%FY 2025: 15.6%
FY 2016 5y median -16.0% FY 2025
ROA 16.3%
FY 2016: -14.8%FY 2017: -18.1%FY 2018: -78.9%FY 2019: -79.9%FY 2020: -51.9%FY 2021: -46.9%FY 2022: -30.6%FY 2023: -9.0%FY 2024: 12.5%FY 2025: 16.3%
FY 2016 5y median -9.0% FY 2025

Growth (YoY)

Revenue 29.9%
FY 2016: 21.1%FY 2017: -2.1%FY 2018: 48.8%FY 2019: 46.7%FY 2020: 28.0%FY 2021: 13.8%FY 2022: 6.8%FY 2023: 16.0%FY 2024: 19.2%FY 2025: 29.9%
FY 2016 FY 2025
Operating Income 85.0%
FY 2016: -40.6%FY 2017: -463.7%FY 2018: -102.6%FY 2019: 5.6%FY 2020: 36.6%FY 2021: -36.4%FY 2022: 31.2%FY 2023: 69.9%FY 2024: 238.0%FY 2025: 85.0%
FY 2016 FY 2025
EPS (diluted) 81.8%
FY 2016: -1.7%FY 2017: -231.2%FY 2018: -134.6%FY 2019: 8.2%FY 2020: 41.1%FY 2021: -21.2%FY 2022: 40.0%FY 2023: 72.5%FY 2024: 266.9%FY 2025: 81.8%
FY 2016 FY 2025
Free Cash Flow 10.0%
FY 2016: -69.0%FY 2017: -139.3%FY 2018: -100.4%FY 2019: 5.2%FY 2020: 49.3%FY 2021: -128.7%FY 2022: 37.2%FY 2023: 145.2%FY 2024: 71.4%FY 2025: 10.0%
FY 2016 FY 2025

Financial Health

Current Ratio 4.9×
FY 2016: 1.8×FY 2017: 7.1×FY 2018: 2.5×FY 2019: 2.2×FY 2020: 2.0×FY 2021: 2.8×FY 2022: 2.6×FY 2023: 2.4×FY 2024: 3.6×FY 2025: 4.9×
FY 2016 5y median 2.8× FY 2025
Quick Ratio 3.8×
FY 2016: 0.9×FY 2017: 6.4×FY 2018: 2.0×FY 2019: 1.5×FY 2020: 1.2×FY 2021: 2.0×FY 2022: 1.8×FY 2023: 1.7×FY 2024: 3.1×FY 2025: 3.8×
FY 2016 5y median 2.0× FY 2025
Debt / Equity 0.0×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -3.2×
FY 2016: 0.4×FY 2017: 2.9×FY 2018: 0.7×FY 2019: 0.6×FY 2020: 0.8×FY 2021: 0.9×FY 2022: 1.1×FY 2023: 7.4×FY 2024: -4.0×FY 2025: -3.2×
FY 2016 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2016: -7.8×FY 2017: -107×FY 2018: -420×FY 2019: -37.0×FY 2020: -280×FY 2021: -492×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31